Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation

Transplantation

Volumn 66, Issue 5, 1998, Pages 610-616

  Muscaritoli, Maurizio ^a   Conversano, Laura ^a   Torelli, Giovanni F ^a   Arcese, William ^a   Capria, Saveria ^a   Cangiano, Carlo ^a   Falcone, Clorinda ^a   Fanelli, Filippo Rossi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELOID LEUKEMIA; PRIORITY JOURNAL; SEPSIS; TOTAL PARENTERAL NUTRITION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PARENTERAL NUTRITION, TOTAL; RECURRENCE;

EID: 0032530723     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199809150-00011     Document Type: Article

References (43)

1. Bociek RG, Stewart DA, Armitage O. Bone marrow transplantation: current concepts. J Invest Med 1995; 43, 2: 127.
2. Gratwohl A. Bone marrow transplantation today. Support Care Cancer 1994; 2: 27.
3. Papadopoulou A, Lloyd DR, Williams MD, Darbyshire PJ, Booth IW. Gastrointestinal and nutritional sequelae of bone marrow transplantation. Arch Dis Child 1996; 75(3): 208.
4. Cunningham BA, Lenssen P, Aker SN, Gittere KM, Cheney CL, Hutchinson MM. Nutritional considerations during marrow transplantation. Nurs Clin North Am 1983; 18: 585.
5. Schmidt GM, Blume KG, Bross KJ, Spruce WE, Waldron JC, Levine R. Parenteral Nutrition in bone marrow transplant recipients. Exp Haematol 1980; 8: 506.
6. Reed MD, Halpin TC, Herzig RH, Gross S. Cyclic parenteral nutrition during allogeneic bone marrow transplantation. J Parenter Enteral Nutr 1981; 3: 95.
7. Weisdorf SA, Hofland C, Sharp HL, et al. Total parenteral nutrition in bone marrow transplantation: a clinical evaluation. J Pediatr Gastroenterol Nutr 1984; 3: 95.
8. ASPEN Board of Directors. Guidelines for the use of total parenteral nutrition in the hospitalized adult patient. J Parenter Enterai Nutr 1993; 17(4) (Suppl): 12SA.
9. Weisdorf SA, Lysne J, Wind D, et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 1987; 43: 6: 833.
10. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987; 47: 3309.
11. Cynober L, Furst P, Lawin P (eds). Pharmacological nutrition, immune nutrition. New York: W. Zuckschwerdt Verlag, 1995.
12. Rossi Fanelli F, Franchi F, Mulieri M, et al. Effect of energy substrate manipulation on tumor cell proliferation in parenterally fed cancer patients. Clin Nutr 1991; 10: 228.
13. Franchi F, Rossi Fanelli F, Seminara P, Cascino A, Barone C, Scucchi L. Cell kinetics of gastrointestinal tumor after different nutritional regimens. J Clin Gastroenterol 1991; 13(3): 313.
14. Kinsella JE, Lokesh B, Broughton S, Whelan J. Dietary polyunsatured fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells; an overview. Nutrition 1990; 5: 24.
15. Kinsella JE. Lipids, membrane receptors, and enzymes: effects of dietary fatty acids. J Parenter Enteral Nutr 1990; 14(5) (Suppl): 200.
16. Meade CJ and Mertin J. Fatty acids and immunity. Adv Lipid Res 1978; 16: 127.
17. Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nomymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983; 309: 1347.
18. Chandra RK, Scrimshaw NS. Immunocompetence in nutritional assessment. Am J Clin Nutr 1980; 33: 2694.
19. Chandra RK. Immunocompetence as a functional index of nutritional status. Br Med Bull 1981; 37: 89.
20. Ramirez I, Van Eys J, Carr D, et al. Immunological evaluation in the nutritional assessment of children with cancer. Am J Clin Nutr 1985; 41: 1314.
21. Muscaritoli M, Conversano L, Cangiano C, et al. Biochemical indices may not accurately reflect changes in nutritional status after allogeneic bone marrow transplantation. Nutrition 1995; 5: 433.
22. Dykes PJ, Francis AJ, Marks R. Measurements of dermal thickness with the Harpenden skinfold caliper. Arch Dermatol Res 1976; 256: 261.
23. Kramer HJ, Ulmer HV. Two-second standardization of the Harpenden caliper. Eur J Appl Physiol 1981; 46: 103.
24. Cheney LC, Abson KG, Aker SN, et al. Body composition changes in marrow transplant recipients receiving total parenteral nutrition. Cancer 1987; 59: 1515.
25. Nash RA, Pepe MS, Storb R, et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 7: 1838.
26. Storb R, Deeg J, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis af acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729.
27. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED. Transplantation 1974; 18(4): 295.
28. Lough M, Watkins R, Campbell M, Carr K, Burnett A, Shenkin A. Parenteral nutrition in bone marrow transplantation. Clin Nutr 1990; 9: 97.
29. Stuart RK, Sensenbrenner LL. Adverse effect of nutritional deprivation on transplanted hematopoietic cells. Exp Hematol 1979; 7: 435.
30. Pasto-Cardona L, Carreras-Pons E, Masso-Muniesa J. Nutricion artificial en el trasplante de medula osea. Nutr Hosp 1990; 5: 295.
31. Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone-marrow transplantation: a randomized, double-blind, controlled study. Ann Intern Med 1992; 116: 821.
32. Espat NJ, Moldawer LL, Copeland EM 3rd. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol 1995; 58: 77.
33. Muscaritoli M, Micozzi A, Conversano L, et al. Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity. Eur J Cancer 1997; 33: 2:319.
34. Hwang D. Essential fatty acids and immune response. FASEB J 1989; 3: 2052.
35. Erickson KL. Dietary fat modulation of immune response. Int J Immunopharmacol 1986; 8: 6: 529.
36. Weiden PL, Flournoy N, Thomas Ed, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 1979; 300: 1068.
37. Weiden PL, Sullivan KM, Flournoy N, et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic bone-marrow transplantation. N Engl J Med 1981; 304: 1529.
38. Kunkel SL, Remick DG, Spengler M, et al. Modulation of macrophage-derived interleukin-1 and tumor necrosis factor by prostaglandin E2. Adv Prostaglandin Thromboxane Leukot Res 1982; 9: 331.
39. Snyder DS, Beller DI, Unanue ER. Prostaglandins modulate macrophage Ia expression. Nature 1982; 299: 163.
40. Fisher A, Durandy A, Griscelli C. Role of prostaglandin E2 in the induction of non-specific T lymphocyte suppressor activity. J Immunol 1982; 126: 1452.
41. Rappaport RS and Dodge GR. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 1982; 155: 943.
42. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330 (12): 827.
43. Clemans GW, Yamanaka W, Flournoy N, et al. Plasma fatty acid patterns of bone marrow transplant patients primarily supported by fat-free parenteral nutrition. J Parenter Enteral Nutr 1981; 5(3): 221.